Related Experiment Video
Updated: Jul 29, 2026

08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Updating a systematic review--what difference did it make? Case study of nicotine replacement therapy
L F Stead1, T Lancaster, C A Silagy
1Cochrane Tobacco Addiction Group, Department of Primary Health Care, Oxford University, UK. lindsay.stead@dphpc.ox.ac.uk
BMC Medical Research Methodology
|December 6, 2001
Summary
Regularly updating systematic reviews on nicotine replacement therapy (NRT) for smoking cessation provides more precise estimates but may not alter the core clinical message. The review
Area of Science:
- Evidence-based medicine
- Systematic reviews and meta-analysis
- Smoking cessation interventions
Background:
- Systematic reviews require regular updates to incorporate new evidence.
- Nicotine replacement therapy (NRT) is a key intervention for smoking cessation.
- The impact of updating a review on its conclusions and scope is not always clear.
Purpose of the Study:
- To assess the effect of updating a systematic review of nicotine replacement therapy (NRT).
- To evaluate changes in meta-analytic findings and review content over time.
- To examine the impact of new trial data on the evidence base for NRT.
Main Methods:
- Compared meta-analyses from 1994 and 2000 for nicotine gum and patch.
- Assessed changes in the number of trials and pooled effect estimates (odds ratio).
- Qualitatively evaluated shifts in review questions and subgroup analyses.
Main Results:
- Nicotine patch trials increased significantly, leading to a more precise effect estimate.
- The pooled effect estimate for the nicotine patch decreased slightly but remained significant.
- Updated reviews addressed new research questions not present in the original version.
Conclusions:
- Updating meta-analyses yields more precise estimates but may not change the overall clinical message for NRT.
- Further placebo-controlled NRT trials may offer diminishing returns to the evidence base.
- There is an inherent tension between pre-defining review questions and adapting to emerging research.
More Related Videos
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...

